NAFDAC blacklists 22 Indian pharmaceutical firms

According to the World Health Organization, counterfeit and sub-standard medicines represent an enormous public health challenge.  These products can range from random mixtures of harmful toxic substances to inactive, useless preparations.  Counterfeiting is greatest in those regions where the regulatory and legal oversight is weakest.  Many countries in Africa and parts of Asia and Latin [...]

Pan-American stakeholders speak out on innovation and public health

As the Pan-American Health Organization (PAHO) meets this week in Washington D.C., so too did a group of key healthcare stakeholders from across the Americas.  As part of their meeting this week, PAHO delegates will be reviewing the World Health Organization’s draft strategy on improving access to medicines and healthcare in developing countries.  While patients, providers, [...]